199 related articles for article (PubMed ID: 31604805)
1. Angiotensinogen in hepatocytes contributes to Western diet-induced liver steatosis.
Tao XR; Rong JB; Lu HS; Daugherty A; Shi P; Ke CL; Zhang ZC; Xu YC; Wang JA
J Lipid Res; 2019 Dec; 60(12):1983-1995. PubMed ID: 31604805
[TBL] [Abstract][Full Text] [Related]
2. Angiotensinogen Exerts Effects Independent of Angiotensin II.
Lu H; Wu C; Howatt DA; Balakrishnan A; Moorleghen JJ; Chen X; Zhao M; Graham MJ; Mullick AE; Crooke RM; Feldman DL; Cassis LA; Vander Kooi CW; Daugherty A
Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):256-65. PubMed ID: 26681751
[TBL] [Abstract][Full Text] [Related]
3. Ellagic acid ameliorates AKT-driven hepatic steatosis in mice by suppressing de novo lipogenesis via the AKT/SREBP-1/FASN pathway.
Zhang C; Hu J; Sheng L; Yuan M; Wu Y; Chen L; Wang G; Qiu Z
Food Funct; 2019 Jun; 10(6):3410-3420. PubMed ID: 31123744
[TBL] [Abstract][Full Text] [Related]
4. MC-LR Aggravates Liver Lipid Metabolism Disorders in Obese Mice Fed a High-Fat Diet via PI3K/AKT/mTOR/SREBP1 Signaling Pathway.
Chu H; Du C; Yang Y; Feng X; Zhu L; Chen J; Yang F
Toxins (Basel); 2022 Nov; 14(12):. PubMed ID: 36548730
[TBL] [Abstract][Full Text] [Related]
5. Betulinic acid alleviates non-alcoholic fatty liver by inhibiting SREBP1 activity via the AMPK-mTOR-SREBP signaling pathway.
Quan HY; Kim DY; Kim SJ; Jo HK; Kim GW; Chung SH
Biochem Pharmacol; 2013 May; 85(9):1330-40. PubMed ID: 23435355
[TBL] [Abstract][Full Text] [Related]
6. Ursodeoxycholic acid ameliorates hepatic lipid metabolism in LO2 cells by regulating the AKT/mTOR/SREBP-1 signaling pathway.
Hu J; Hong W; Yao KN; Zhu XH; Chen ZY; Ye L
World J Gastroenterol; 2019 Mar; 25(12):1492-1501. PubMed ID: 30948912
[TBL] [Abstract][Full Text] [Related]
7. Cys18-Cys137 disulfide bond in mouse angiotensinogen does not affect AngII-dependent functions in vivo.
Wu C; Xu Y; Lu H; Howatt DA; Balakrishnan A; Moorleghen JJ; Vander Kooi CW; Cassis LA; Wang JA; Daugherty A
Hypertension; 2015 Apr; 65(4):800-5. PubMed ID: 25691624
[TBL] [Abstract][Full Text] [Related]
8. Effects of the new thiazolidine derivative LPSF/GQ-02 on hepatic lipid metabolism pathways in non-alcoholic fatty liver disease (NAFLD).
Araújo S; Soares E Silva A; Gomes F; Ribeiro E; Oliveira W; Oliveira A; Lima I; Lima MDC; Pitta I; Peixoto C
Eur J Pharmacol; 2016 Oct; 788():306-314. PubMed ID: 27349145
[TBL] [Abstract][Full Text] [Related]
9. O-1602 Promotes Hepatic Steatosis through GPR55 and PI3 Kinase/Akt/SREBP-1c Signaling in Mice.
Kang S; Lee AY; Park SY; Liu KH; Im DS
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33803038
[TBL] [Abstract][Full Text] [Related]
10. Targeting arginase-II protects mice from high-fat-diet-induced hepatic steatosis through suppression of macrophage inflammation.
Liu C; Rajapakse AG; Riedo E; Fellay B; Bernhard MC; Montani JP; Yang Z; Ming XF
Sci Rep; 2016 Feb; 6():20405. PubMed ID: 26846206
[TBL] [Abstract][Full Text] [Related]
11. Thyrotropin increases hepatic triglyceride content through upregulation of SREBP-1c activity.
Yan F; Wang Q; Lu M; Chen W; Song Y; Jing F; Guan Y; Wang L; Lin Y; Bo T; Zhang J; Wang T; Xin W; Yu C; Guan Q; Zhou X; Gao L; Xu C; Zhao J
J Hepatol; 2014 Dec; 61(6):1358-64. PubMed ID: 25016220
[TBL] [Abstract][Full Text] [Related]
12. LRG ameliorates steatohepatitis by activating the AMPK/mTOR/SREBP1 signaling pathway in C57BL/6J mice fed a high‑fat diet.
Hao T; Chen H; Wu S; Tian H
Mol Med Rep; 2019 Jul; 20(1):701-708. PubMed ID: 31180545
[TBL] [Abstract][Full Text] [Related]
13. Hepatocyte-specific PKCβ deficiency protects against high-fat diet-induced nonalcoholic hepatic steatosis.
Shu Y; Hassan F; Coppola V; Baskin KK; Han X; Mehta NK; Ostrowski MC; Mehta KD
Mol Metab; 2021 Feb; 44():101133. PubMed ID: 33271332
[TBL] [Abstract][Full Text] [Related]
14. Two Amino Acids Proximate to the Renin Cleavage Site of Human Angiotensinogen Do Not Affect Blood Pressure and Atherosclerosis in Mice-Brief Report.
Wu CH; Wu C; Howatt DA; Moorleghen JJ; Cassis LA; Daugherty A; Lu HS
Arterioscler Thromb Vasc Biol; 2020 Sep; 40(9):2108-2113. PubMed ID: 32640904
[TBL] [Abstract][Full Text] [Related]
15. Long Noncoding RNA lncSHGL Recruits hnRNPA1 to Suppress Hepatic Gluconeogenesis and Lipogenesis.
Wang J; Yang W; Chen Z; Chen J; Meng Y; Feng B; Sun L; Dou L; Li J; Cui Q; Yang J
Diabetes; 2018 Apr; 67(4):581-593. PubMed ID: 29382663
[TBL] [Abstract][Full Text] [Related]
16. Branched Chain Amino Acids Cause Liver Injury in Obese/Diabetic Mice by Promoting Adipocyte Lipolysis and Inhibiting Hepatic Autophagy.
Zhang F; Zhao S; Yan W; Xia Y; Chen X; Wang W; Zhang J; Gao C; Peng C; Yan F; Zhao H; Lian K; Lee Y; Zhang L; Lau WB; Ma X; Tao L
EBioMedicine; 2016 Nov; 13():157-167. PubMed ID: 27843095
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA lncARSR promotes hepatic lipogenesis via Akt/SREBP-1c pathway and contributes to the pathogenesis of nonalcoholic steatohepatitis.
Zhang M; Chi X; Qu N; Wang C
Biochem Biophys Res Commun; 2018 Apr; 499(1):66-70. PubMed ID: 29555473
[TBL] [Abstract][Full Text] [Related]
18. Hepatic mTOR-AKT2-Insig2 signaling pathway contributes to the improvement of hepatic steatosis after Roux-en-Y Gastric Bypass in mice.
Pan Q; Qin T; Gao Y; Li S; Li D; Peng M; Zhai H; Xu G
Biochim Biophys Acta Mol Basis Dis; 2019 Mar; 1865(3):525-534. PubMed ID: 30562559
[TBL] [Abstract][Full Text] [Related]
19. Scutellarin, a modulator of mTOR, attenuates hepatic insulin resistance by regulating hepatocyte lipid metabolism via SREBP-1c suppression.
Luan H; Huo Z; Zhao Z; Zhang S; Huang Y; Shen Y; Wang P; Xi J; Liang J; Wu F
Phytother Res; 2020 Jun; 34(6):1455-1466. PubMed ID: 31828866
[TBL] [Abstract][Full Text] [Related]
20. Functional Exploration of Conserved Sequences in the Distal Face of Angiotensinogen-Brief Report.
Amioka N; Wu CH; Sawada H; Ito S; Pettey AC; Wu C; Moorleghen JJ; Howatt DA; Graf GA; Vander Kooi CW; Daugherty A; Lu HS
Arterioscler Thromb Vasc Biol; 2023 Aug; 43(8):1524-1532. PubMed ID: 37345525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
